GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Inventories, Inventories Adjustments

Radiopharm Theranostics (ASX:RAD) Inventories, Inventories Adjustments : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Inventories, Inventories Adjustments?

Radiopharm Theranostics's Inventories, Inventories Adjustments for the quarter that ended in Dec. 2023 was A$0.00 Mil.


Radiopharm Theranostics Inventories, Inventories Adjustments Historical Data

The historical data trend for Radiopharm Theranostics's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Inventories, Inventories Adjustments Chart

Radiopharm Theranostics Annual Data
Trend Jun22 Jun23
Inventories, Inventories Adjustments
- -

Radiopharm Theranostics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Inventories, Inventories Adjustments - - - - -

Radiopharm Theranostics Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.


Radiopharm Theranostics (ASX:RAD) Business Description

Industry
Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (ASX:RAD) Headlines

No Headlines